PF-04634817 structure
|
Common Name | PF-04634817 | ||
---|---|---|---|---|
CAS Number | 1228111-63-4 | Molecular Weight | 511.58 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H36F3N5O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PF-04634817PF-0463481, an oral CCR2/5 dual antagonist, with a favorable ocular safety profile versus intravitreal therapies[1]. PF-0463481 is safe and well-tolerated and being developed for the treatment of diabetic nephropathy[2]. |
Name | PF-04634817 |
---|
Description | PF-0463481, an oral CCR2/5 dual antagonist, with a favorable ocular safety profile versus intravitreal therapies[1]. PF-0463481 is safe and well-tolerated and being developed for the treatment of diabetic nephropathy[2]. |
---|---|
Related Catalog | |
Target |
CCR2 CCR5 |
References |
Molecular Formula | C25H36F3N5O3 |
---|---|
Molecular Weight | 511.58 |